Literature DB >> 25771739

Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.

Chao Liu1, Liang Fang2.   

Abstract

The objective of the present study was to develop transdermal patch for zolmitriptan, determine its in vivo absorption using the rabbit skin. Solvent evaporation technique prepared zolmitriptan patch was settled in two-chamber diffusion cell combined with excised rabbit abdomen skin for permeation study. A sufficient cumulative penetration amount of zolmitriptan (258.5 ± 26.9 μg/cm(2) in 24 h) was achieved by the formulation of 4% zolmitriptan, 10% Azone, and adhesive of DURO-TAK® 87-4098. Pharmacokinetic parameters were determined via i.v. and transdermal administrations using animal model of rabbit. The results revealed that the absolute bioavailability was about 63%. Zolmitriptan could be detected with drug level of 88 ± 51 ng/mL after transdermal administration of 15 min. The in vivo absorption curve obtained by deconvolution approach using WinNonlin® program was correlated well with the in vitro permeation curve, the correlation coefficient R is 0.84, and the result indicated that in vitro skin permeation experiments were useful to predict the in vivo performance. In addition, little skin irritation was found in the irritation study. As a conclusion, the optimized zolmitriptan transdermal patches could effectively deliver adequate drug into systemic circulation in short time without producing any irritation phenomenon and worth to be developed.

Entities:  

Keywords:  chemical enhancer; drug-in-adhesive patch; in vitro/in vivo correlation; pharmacokinetic; zolmitriptan

Mesh:

Substances:

Year:  2015        PMID: 25771739      PMCID: PMC4666264          DOI: 10.1208/s12249-015-0303-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  24 in total

1.  High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection.

Authors:  Jun Chen; Xin-Guo Jiang; Wen-Ming Jiang; Ni Mei; Xiao-Ling Gao; Qi-Zhi Zhang
Journal:  J Pharm Biomed Anal       Date:  2004-05-28       Impact factor: 3.935

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo.

Authors:  Sonal R Patel; Hui Zhong; Ashutosh Sharma; Yogeshvar N Kalia
Journal:  Eur J Pharm Biopharm       Date:  2008-08-19       Impact factor: 5.571

4.  Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.

Authors:  Robhash Kusam Subedi; Je-Phil Ryoo; Cheol Moon; Hoo-Kyun Choi
Journal:  Int J Pharm       Date:  2011-08-16       Impact factor: 5.875

5.  Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron.

Authors:  Lin Sun; Dongmei Cun; Bo Yuan; Hongxia Cui; Honglei Xi; Liwei Mu; Yang Chen; Chao Liu; Zhongyan Wang; Liang Fang
Journal:  J Pharm Sci       Date:  2012-09-12       Impact factor: 3.534

6.  In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.

Authors:  Satyanarayana Valiveti; Dana C Hammell; Kalpana S Paudel; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  J Control Release       Date:  2005-02-02       Impact factor: 9.776

7.  Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans.

Authors:  F G Moeller; J M Bjork; D M Dougherty; L D Van de Kar; D M Marsh; A C Swann
Journal:  Psychoneuroendocrinology       Date:  2000-08       Impact factor: 4.905

8.  A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.

Authors:  Yinghua Sun; Liang Fang; Meng Zhu; Wei Li; Ping Meng; Li Li; Zhonggui He
Journal:  Int J Pharm       Date:  2009-08-28       Impact factor: 5.875

9.  Effect of unsaturated menthol analogues on the in vitro penetration of 5-fluorouracil through rat skin.

Authors:  Yang Chen; Jian Wang; Dongmei Cun; Manli Wang; Juan Jiang; Honglei Xi; Hongxia Cui; Yongnan Xu; Maosheng Cheng; Liang Fang
Journal:  Int J Pharm       Date:  2013-01-16       Impact factor: 5.875

Review 10.  Acute and preventive treatment of migraine.

Authors:  Paul B Rizzoli
Journal:  Continuum (Minneap Minn)       Date:  2012-08
View more
  3 in total

1.  Design and Evaluation of a Novel Felbinac Transdermal Patch: Combining Ion-Pair and Chemical Enhancer Strategy.

Authors:  Nannan Liu; Wenting Song; Tian Song; Liang Fang
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

2.  Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study.

Authors:  Doaa H Hassan; Joseph N Shohdy; Doaa Ahmed El-Setouhy; Mohamed El-Nabarawi; Marianne J Naguib
Journal:  Pharmaceutics       Date:  2022-07-18       Impact factor: 6.525

3.  Mechanistic insights of the controlled release capacity of polar functional group in transdermal drug delivery system: the relationship of hydrogen bonding strength and controlled release capacity.

Authors:  Zheng Luo; Chao Liu; Peng Quan; Degong Yang; Hanqing Zhao; Xiaocao Wan; Liang Fang
Journal:  Acta Pharm Sin B       Date:  2019-11-29       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.